| Product Information |
|
| Registration Number |
BR-1207
|
| Generic Name |
Vedolizumab
|
| Brand Name |
Entyvio
|
| Dosage Strength |
300 mg
|
| Dosage Form |
Powder for Concentrate for Solution for
Infusion (IV)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
20 mL Type I clear glass vial with rubber stopper aluminum seal with a white plastic flip-off cap (Box of 1's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Takeda Pharmaceutical Company Limited (Hikari Plant)
|
| Country of Origin |
Japan
|
| Trader |
Takeda Pharma A/S
|
| Importer |
Takeda Healthcare Philippines Inc.
|
| Distributor |
N/A
|
| Application Type |
Initial [from Monitored Release] (Reconstruction)
|
| Issuance Date |
16 January 2024
|
| Expiry Date |
24 February 2027
|